Main Category: Women's Health / Gynecology
Also Included In: Medical Devices / Diagnostics
Article Date: 26 Apr 2011 - 3:00 PDT email to a friend � printer friendly � opinions �
Current Article Ratings:
Patient / Public: | ||
Healthcare Prof: | 2 (1 votes) |
The French medical device regulator, AFSSAPS, has released the findings of comprehensive testing carried out on Poly Implant Prosthese (PIP) silicone breast implants following health concerns raised in 2010.
These results confirm the UK findings reported in September last year that there was no evidence of genotoxicity (potential for cancer) or chemical toxicity of the filler material inside the devices.
PIP was one of the major breast implant manufactures for the UK and approximately 40,000 women in the UK have been implanted with PIP silicone breast implants (80,000 implants).
Medicines and Healthcare products Regulatory Agency (MHRA) Clinical Director for Devices, Dr Susanne Ludgate, said: "We wanted to identify any potential toxicity associated with the implant filler as soon as possible, to protect the health of anyone who had used it.
"We are extremely pleased that these further tests have again found no dangerous substances.
"This action is part of the MHRA's ongoing goal to keep watch over medicines and medical devices, and take any action needed to protect the public as swiftly as possible if there are any health issues.
"We are pleased that women in the UK with these implants can be reassured as a result of these findings."
Notes
1. The MHRA is the government agency responsible for ensuring that medicines and medical devices work, and are acceptably safe. No product is risk-free. Underpinning all our work lie robust and fact-based judgements to ensure that the benefits to patients and the public justify the risks. We keep watch over medicines and devices, and take any necessary action to protect the public promptly if there is a problem. We encourage everyone - the public and healthcare professionals as well as the industry - to tell us about any problems with a medicine or medical device, so that we can investigate and take any necessary action.
2. The MHRA was informed in March 2010 by AFSSAPS that they had suspended the company's marketing, distribution and export of these products. This was due to an inspection of PIP's manufacturing plant which found that most implants manufactured since 2001 had been filled with an unauthorised silicone gel which differed from the originally approved material.
3. In general, a medical device cannot be marketed in the UK without carrying a CE Mark of Conformity. A CE mark is applied by the manufacturer to denote that the device meets the relevant regulatory requirements and performs as intended. For all but the very lowest risk devices, such as unmedicated bandages, an EC Certificate of Conformity must be obtained from an independent certification organisation, called a Notified Body, before the CE marking can be affixed. The MHRA is responsible for designating UK Notified Bodies and regularly audits them to ensure that they continue to perform to the required standards.
4. The AFSSAPS's recommendation can be viewed here: Silicone filled breast implants from Poly Implant Proth�se Company - Test results: see here.
5. The Medical Device Alert can be viewed here: Medical Device Alert: Silicone gel filled breast implants manufactured by Poly Implant Prothese (PIP) - All models and lot numbers: see here.
6. For further information about breast implants, see the MHRA website: see here.
7. Adverse incidents relating to medical devices can be reported via the MHRA website.
Please rate this article: (Hover over the stars then click to rate) | Patient / Public: | or | Health Professional: |
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Privacy Policy | Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd � 2004-2011 All rights reserved.
Source: http://www.medicalnewstoday.com/articles/223308.php
health and fitness women health clubs for women pregnancy health issues health and fitness for women heart health women
No comments:
Post a Comment